Tumor microenvironment responsive mesoporous silica nanoparticles for dual delivery of doxorubicin and chemodynamic therapy (CDT) agent
- 16 January 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 44 (6) , 2578-2586
Abstract
Chemodynamic therapy is a new antitumor strategy triggered by transition metal as chemodynamic agent via the in situ catalytic Fenton reaction. Herein, we engineer a smart nanocarrier activated by tumor microenvironment-specific weak acidic pH and high glutathione conditions for chemo/chemodynamic processes. This unique architecture orderly consists of mesosilica-encapsulated doxorubicin, self-polymerization of polydopamine Fe3+ clathrate, further bonding the targeting polymer MnO2 disguised albumin–folic acid. Polydopamine and albumin as intelligent nanovalves shield doxorubicin from premature leaking. Folic acid improves the targeting capability for folate receptor (FR) overexpressing cancer cells. After intake of the nanocarrier by tumor cells, the nanocarrier nanovalves are first biodegraded by native glutathione and pH, enabling on-demand anticancer drug escape, and also generate and release Fe3+ and Mn2+ (reduced by MnO2via glutathione depletion). Subsequently, the ions interact with H2O2, generating highly toxic hydroxyl radicals (˙OH) via a Fenton-like reaction to enhance the anticancer cell efficacy. This result proves that the designed nanocarrier more likely devours into FR-positive cancer cells and illustrates a high intracellular ˙OH generation, leading to the desired specific killing efficacy. We believe this innovative strategy will exhibit a new avenue for the potential of accurate chemo/chemodynamic co-therapy in cancer cells.Keywords
Funding Information
- National Natural Science Foundation of China (21874087)
- National Natural Science Foundation of China (21575084)
- Shanxi Scholarship Council of China (2017-Key1)
This publication has 37 references indexed in Scilit:
- Folate‐Conjugated Polylactic Acid–Silica Hybrid Nanoparticles as Degradable Carriers for Targeted Drug Delivery, On‐Demand Release and Simultaneous Self‐ClearanceChempluschem, 2016
- Protein‐Nanoreactor‐Assisted Synthesis of Semiconductor Nanocrystals for Efficient Cancer TheranosticsAdvanced Materials, 2016
- Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapyBiomaterials, 2016
- MMP-responsive theranostic nanoplatform based on mesoporous silica nanoparticles for tumor imaging and targeted drug deliveryJournal of Materials Chemistry B, 2016
- Immune response to functionalized mesoporous silica nanoparticles for targeted drug deliveryNanoscale, 2015
- Molecular and supramolecular switches on mesoporous silica nanoparticlesChemical Society Reviews, 2015
- Enzyme-Induced and Tumor-Targeted Drug Delivery System Based on Multifunctional Mesoporous Silica NanoparticlesACS Applied Materials & Interfaces, 2015
- Heat-triggered drug release systems based on mesoporous silica nanoparticles filled with a maghemite core and phase-change molecules as gatekeepersJournal of Materials Chemistry B, 2013
- Functionalized mesoporous silica materials for controlled drug deliveryChemical Society Reviews, 2012
- A Mesoporous Silica Nanosphere-Based Carrier System with Chemically Removable CdS Nanoparticle Caps for Stimuli-Responsive Controlled Release of Neurotransmitters and Drug MoleculesJournal of the American Chemical Society, 2003